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The research presented in this dissertation deals with the phenomena of 
bacterial efflux pump inhibition by natural products and plant extracts. Bacterial 
efflux pumps are active transport proteins, primarily deriving their energy source 
from the proton motive force, which functions to export toxic compounds outside 
the cell. This is a natural defense mechanism that bacteria utilize to protect 
themselves from toxic environments. The over-production of efflux pumps is one 
mechanism by which bacteria can evolve resistance to clinical antibiotics, as well 
as other antimicrobials. Thus, the study of efflux pump inhibitors is important 
because it holds the potential to reverse some forms of antibiotic resistance. In 
light of this importance, a series of studies were designed to improve the ability to 
study this phenomenon, to investigate the distribution of efflux pump inhibition in 
land plants, and to improve our ability to identify an important class of efflux 
pump inhibitors, the flavonoids. 
The first aim of this research was to develop an improved method for 
experimentally quantifying efflux pump inhibitory activity of small molecules. 
Preexisting methods made this difficult due to several limitations including: the 
collection of indirect results, time consuming materials handling techniques, 
and/or matrix interference problems pertaining to the quenching of fluorescent 
signal. An improved method relying on mass spectrometry measurements was 
developed that addressed the aforementioned limitations. The importance of this 
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improved method lies in its ability to produce data sets useful in calculating IC50 
values for a wider range of samples than was previously possible. 
The second aim was to evaluate the presence of efflux pump inhibitor 
production across the land plant lineage. This is important to botanical science 
and the understanding of plant-microbe interactions and plant evolutionary 
biology.  The most ancient lineages of land plants have not been previously 
evaluated for efflux inhibitory activity. Additionally, land plants play an important 
role in many traditional medicinal systems and in modern complementary and 
alternative medicine.  Thus, understanding the distribution of efflux pump inhibitor 
production in this group increases our understanding of these common forms of 
medical treatment. In order to gain these data, a set of 14 plant species spanning 
the major lineages within the land plant group (bryophytes, pterophytes and 
lycophytes, gymnosperms, and angiosperms) were extracted and assayed to 
determine efflux pump inhibitory activity of the extracts. Positive results 
(indicating the presence of an efflux pump inhibitor) were observed for many (but 
not all) of the plant species tested. The observation of activity in extracts 
prepared from the most ancient plants tested (bryophytes—the liverworts and 
mosses) lends credence to the hypothesis that the production of efflux pump 
inhibitors is of great antiquity in land plants. 
The last component of this work was the evaluation of methods for the 
analysis of flavonoids via mass spectrometry. This is of importance to this study 
due to the commonality of flavonoids in the literature pertaining to efflux pump 
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inhibitors, and the consistency activity of the flavonoids evaluated in Chapter II. 
The goal of this work was to compare two methods for the tentative identification 
of signals in complex data produced via high-resolution mass spectrometry that 
could be labeled as “possible flavonoids.” The methods evaluated were firstly the 
use of mass spectrometry fragmentation spectra to identify key diagnostic 
fragments of the flavonoid ring structure and secondly the use of mass defect 
filtering directly applied to high resolution data to select a short list of signals for 
further processing. The former method was not fruitful due to a combination of 
the frequent poor fragmentation and the dependency on standards for all 
samples. The latter proved more useful, successfully producing a list of potential 
flavonoids to be carried forward to other methods such as database searching 
and molecular formula calculation. This method was also successfully applied to 
a complex extract of Hydrastis canadensis, identifying three flavonoids known 
from previous work to be present. Further, the mass defect method is an intrinsic 
property of molecules, and therefore does not change with experimental 
conditions. For all of these reasons mass defect was selected as the more useful 
of the two methods evaluated for the identification of “possible flavonoid” signals 
in crude extracts. 
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CHAPTER I 
 
INTRODUCTION AND BACKGROUND 
 
 
 The advent and increased usage of modern antibiotics has resulted in a 
dramatic reduction in deaths due to bacterial infections.  However, in more recent 
times, there has been an increase in the abundance of bacterial strains that are 
resistant to these drugs.   MRSA, methicillin-resistant Staphylococcus aureus, is 
an excellent example of drug resistant bacterium that has been on the rise in 
both the clinical and community settings since the 1960’s. One series of 
estimates for the damage caused by MRSA in the United States in 2005 claims 
94,360 MRSA infections resulting in 18,650 deaths in the same year (Klevens et 
al. 2007).  Antimicrobial resistance can evolve through multiple pathways, but 
only one is of importance to this study.  This pathway is the over-expression of 
efflux pumps that export the antimicrobial out of the bacterial cell, preventing it 
from building up to toxic levels (Simões et al. 2009). 
 The research described in this dissertation focuses on the identification of 
botanical secondary metabolites that function to inhibit bacterial efflux pumps.  
The purpose of these studies is three fold.  The first goal was to develop an 
improved assay for the measurement of efflux pump inhibitory activity across a 
diversity of sample types.  The second was to elucidate the distribution of efflux 
pump inhibitory activity in land plants.  Lastly, we sought to improve methods for 
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tentative identification of flavonoids (an important class of efflux pump inhibitory 
compounds) in complex mixtures in cases where analytical standards are not 
available.  These three goals correspond to the research laid out in chapters two, 
three and four, respectively. 
 This research is important both for providing new insights into evolutionary 
biology of land plants, and also facilitating future studies aimed at the 
identification of efflux pump inhibitors from natural product sources.   The 
research described in this dissertation focuses on the identification of botanical 
secondary metabolites that function to inhibit bacterial efflux pumps.  This 
research is important both for providing new insights into evolutionary biology of 
land plants, and also facilitating future studies aimed at the identification of efflux 
pump inhibitors from natural product sources.   
Background on Bacterial Efflux Pumps 
 A number of efflux pumps exist, in both prokaryotic and eukaryotic cells.  
One class of efflux pumps is driven by the cleavage of ATP, allowing molecules to 
be pumped against a diffusion gradient.  Most of the remaining classes of efflux 
pumps use the proton motive force to drive active transport.  The last group 
(those driven by the proton motive force) and the NorA efflux pump in particular 
(a member of this group) are the most prominent in Staphylococcus aureus 
(Abramson et al. 2003,Huang et al. 2003,Sabatini et al. 2008,Saidijam et al. 
2006,Yin et al. 2006).  The inhibition of these efflux pumps can dramatically 
increase the activity of a wide range of antimicrobials in vitro (Tegos et al. 2002). 
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Background on the Relevance of Efflux Pump Inhibitors to Existing Human 
Medicinal Plant Usage 
 A number of studies have shown that many individuals around the world 
are turning to complementary and alternative medicine (CAM), with herbal 
supplements being a particularly prominent part of such CAM treatments.  An 
early study on the usage of CAM in the United States published in 1993 
(Eisenberg et al. 1993) found that 34% of Americans use some form of 
alternative treatment.  Two later studies show the specific usage of natural 
products are an important component of CAM—with these natural products being 
used by 19% (Barnes et al. 2004) in a 2004 study and by 18% in a 2008 study 
(Barnes and Bloom 2008). 
 Ethnobotanical work can inform the scientific community regarding the us-
age of medicinal plants in a broader context.  One of the often noted observa-
tions of ethnobotanists is that plants are used in combinations (Bussmann et al. 
2010, Vandebroek et al. 2010, Odhiambo et al. 2011).  Even if this was not the 
case, the field of phytochemistry provides many illustrations pertaining to the 
complexity of plant extracts.  It is common to begin work on an active plant ex-
tract, and then observe incremental losses in activity as the “active” compound is 
purified.  Alternatively, it is also common for the “active” compound to be present 
at too low a concentration to explain the totality of the observed activity. This 
leads to the conclusion that some mechanism of activity is present in the extract 
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which is lost upon purification.  This is likely due to synergistic interactions (non-
additive positive interactions between mixture components) between multiple 
compounds (Bame et al. 2013, Berenbaum 1989, Junio et al. 2011, Stermitz et 
al. 2000b).  The possibility of synergistic interactions complicates any study seek-
ing to either validate the efficacy of a particular preparation or to discover its 
mechanism of action.  In light of these observations, more studies dealing specif-
ically with mechanisms of synergy are needed. 
Significance to Public Health 
This body of research is significant to public health because it relates to 
the problem of emerging drug resistance.  The overproduction of efflux pumps is 
a common form of drug resistance, so identification of new efflux pump inhibitors 
is expected to hasten the development of effective adjuvant therapies to existing 
antibiotics (Lomovskaya and Bostian 2006).  Toward this goal, this research is in 
large part aimed at improving methods for identifying efflux pump inhibitors.  
Secondly, a better understanding of plant derived efflux pump inhibitors is 
expected lead to improved application of existing plant-derived CAM therapies.  
Thirdly, by exploring the distribution of efflux pump inhibitors in plants; this 
research will increase our understanding of plant biology and evolution, as 
discussed in greater detail in Chapter III. 
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Significance to Plant Biology 
This research seeks to fill two gaps in the plant biology literature.  The first 
is the description of the distribution of efflux pump inhibitors in land plants.  While 
efflux pump inhibitors have been identified previously, their overall distribution is 
unknown.  The significant body of literature describing natural products that are 
active against bacterial efflux pumps is summarized and cited in Table 1.1. This 
literature demonstrates two things.  The first of these is that while there are 
several classes of compounds that have been found to be active against 
bacterial efflux pumps, the flavonoids are the most common (Table 1.1).  
Secondly, efflux pump inhibitory activity is widely distributed in the angiosperms 
(flowering plants) (Table 1.1).  There is one gymnosperm mentioned in the 
literature, and no monocots or any of the land plant groupings more ancient than 
the gymnosperms (Table 1.1).  This makes it impossible to draw any conclusions 
regarding the evolutionary history of efflux pump inhibitors beyond the 
observation that it appears to be common in the eudicot clade.  The second area 
of study will address the apparent commonness of efflux pump inhibitory activity 
in the flavonoid chemical family.   Towards this end, we sought to discover 
whether or not efflux pump inhibitory flavonoids are common throughout the set  
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Table 1.1. Summarized Literature Demonstrating the Occurrence of 
Plants Producing Bacterial Efflux Pump Inhibitors 
Plant Efflux Pump Inhibitory Compound(s) a 
Gymnosperms:  
Chamaecyparis 
lawsoniana 
Various diterpines, including totarol and ferruginol 
(*)(#) 
(Smith et al. 2007a, 2007b) 
Angiosperms:  
Artemisia annua Flavones (*) 
(Gibbons 2004, 2005, Stermitz et al. 2002) 
Berberis 
spp.,including B. 
fremontii, B. 
trifoliolata, B. 
fendleri 
Pheophorbide a porphyrin, 5’-methoxyhydnocarpin a 
flavolignan(*)(#) 
(Gibbons 2004, 2005, Guz et al. 2001, Stavri et al. 
2007, Stermitz et al. 2000a, 2000b, 2001) 
Camellia 
sinensis 
Epicatechin gallate and epigallocatechin gallate 
(*)(#), substituted flavonoids 
(Hamilton-Miller and Shah 2000,  Simões et al. 2009, 
Stavri et al. 2007) 
Citrus paradisi coumarin and bergamottin derivitives (*) 
(Abulrob et al. 2004, Stavri et al. 2007) 
Dalea versicolor, 
D. spinosa 
Multiple phenolics, including flavonoids, stilbinoids, 
an arylbenzofuran aldehyde, a pterocarpan (*) 
(Belofsky et al. 2004, 2006, Stavri et al. 2007) 
Geranium 
caespitosum 
Polyacylated neohesperidosides(*) 
 (Stavri et al. 2007, Stermitz et al. 2003, Gibbons 
2004, 2005) 
Hydrastis 
canadensis 
A flavonoid (*)(#) 
( Ettefagh et al. 2011, Junio et al. 2011)   
Ipomea 
murucoides 
Various Oligosaccharides(*)(#) 
(Chérigo et al. 2009, Gibbons et al. 2003, Stavri et al. 
2007, Stermitz et al. 2003)   
Jatropha 
elliptica 
A penta-substituted pyridine, propacine a  coumarin 
lignin (*)(#) 
(Marquez et al. 2005, Stavri et al. 2007) 
Lupinus 
argenteus 
Genistein, orobol, biochanin A, isoflavones(*) 
(Gibbons 2004, Morel et al. 2003, Stavri et al. 2007) 
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Lycopus 
europaeus 
Various terpinoids(*) 
(Gibbons et al. 2003, Gibbons 2004, 2005, Stavri et 
al. 2007) 
Mirabilis jalapa Polyphenolic amide derivitives (*)(#) 
(Michalet et al. 2007) 
Piper nigrum, P. 
longum 
Piperine, an alkaloid (*) 
(Khan et al. 2006, Nargotra et al. 2009, Stavri et al. 
2007) 
Prosopis juliflora Piperidine alkaloids (#) 
(Gibbons 2005, Stavri et al. 2007) 
Rauwolfia 
vomitoria 
Reserpine, alkaloid(#) 
(Brenwald et al. 1998, Gibbons 2005, Simões et al. 
2009, Stavri et al. 2007) 
Rosmarinus 
officinalis 
Carnosic acid, a diterpine(#) 
(Gibbons 2005, Oluwatuyi et al. 2004, Stavri et al. 
2007) 
Silybum 
marianum 
Silybin, a flavolignin(*) 
(Gibbons 2004, Stavri et al. 2007 Stermitz et al. 
2000a) 
Thymus vulgaris Baicalein, a trihydroxy flavones (*) 
(Stavri et al. 2007) 
Plant extracts which have shown either synergy or EPI activity, for which the active compound 
is unknown: 
 
Berberis aetnensis, Mezoneuron benthamianum, Securinega virosa, Punica granatum, 
Commiphora molmol, Centella asiatica, Daucus carota, Citrus aurantium, Glycyrrhiza glabra 
[as reviewed by  (Stavri et al. 2007)] 
 
a. Methods used to identify efflux pump inhibitory activity:  (*) = tested for synergy with efflux 
pump substrates, (#) = tested directly for efflux pump inhibitory activity. 
 
 
 Knowledge pertaining to the question of flavonoid activity against bacterial 
efflux pumps is related to the knowledge of how this activity is distributed in land 
plants.  This relationship exists because flavonoids are important and well-
studied compounds within land plants and some algal lineages.  The most 
ancient of all plant groups to produce flavonoids is the algal order Charales, 
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which is a sister group to the land plants (Becker and Marin 2009, Delwiche et al. 
2002, Garbary et al. 1993, lwashina 2000, Markham and Porter 1969b, Stafford 
1991). These algae produce the simple flavonoids apigenin and luteolin, the 
production of which is carried on in the simplest land plants, the liverworts 
(lwashina 2000, Markham and Porter 1969a, 1969b).  The diversity of flavonoids 
produced increases in plants more derived than the liverworts, making this class 
of compounds in all its forms important markers of land plant evolution (Harborn 
1977, lwashina 2000, Stafford 1991).  Flavonoids are also produced in some 
fungal lineages (lwashina 2000), but these are not evaluated in this study. 
Significance to Bioanalytical Chemistry  
In additional to the significance to plant biology and human health, this 
research is significant to the field of bioanalytical chemistry because it advances 
methods for studying the phenomenon of efflux pump inhibition.  The efflux 
inhibition assay most often used in the literature (Ettefagh et al. 2011, Kaatz et al. 
2000, Lechner et al. 2008, Pereda-Miranda et al. 2006, Sabatini et al. 2008, 
Schindler et al. 2013, Stermitz et al. 2000, Tegos et al. 2002) is based on time 
series data measuring the rate of efflux of ethidium bromide (abbreviated EtBr, a 
well known efflux pump substrate) from cells pre-loaded with this compound.  
Data in this assay are collected in the form of changes in the fluorescent intensity 
of EtBr.  The existing assays are non-robust because efflux pumps export the 
EtBr extremely rapidly.  Preliminary experiments (Baer et al. 1982,Howitz et al. 
2003,Hudson et al. 2009, Remans et al. 1999, Matsuura et al. 2002) revealed 
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that another problem with the use of fluorescence is the fact that many 
compounds can quench or otherwise interfere with a fluorescent signal, which 
will be discussed at greater length in Chapter II of this dissertation.  To get 
around this problem, we sought to develop a new assay based on the use of 
mass spectrometry to detect changes in EtBr concentrations.  
 The final objective of this research effort was to evaluate methods for the 
identification and dereplication of flavonoids in crude plant extracts.  The 
literature already reviewed within this chapter strongly hints at the importance of 
flavonoids as efflux pump inhibitors, and discusses their commonality in land 
plant lineages.  In light of this, mass spectrometric methods for rapidly 
determining the flavonoid content of a mixture could be useful research tools.  
There are three groupings of methodologies for the determination of flavonoids 
via mass spectrometry in the current literature.  The first and most common of 
these is the a priori choice and use of standards to quantify a specific set of 
flavonoids (Brolis et al. 1998,Justesen et al. 1998, Volpi and Bergonzini 2006).  
This method is used extensively within Chapter III.  However, the ability to 
evaluate flavonoid content without a priori decisions as to which specific 
molecules are going to be important could also be useful.  Therefore, there is 
need for methods which could be used to reduce a complex data set to a “short 
list” of signals which may be flavonoids, to facilitate further follow-up analysis.  
There are two such methods present in the literature.  The first of these is the use 
of MS-MS fragmentation studies to identify potential flavonoids (Cuyckens and 
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Claeys 2004,Justesen 2001, March et al. 2004a, 2004b, March and Brodbelt 
2008,Zhang and Brodbelt 2003,Zhou et al. 2007).  The second method involves 
the filtering of high-resolution mass spectra based on mass defect parameters 
(Gu et al. 2011, Hughey et al. 2001,Sleno 2012, Wu et al. 2004, Zhang et al. 
2009), which has been increasing in prominence with the proliferation of higher 
resolution mass spectrometers.  These last two methods are compared and 
evaluated in Chapter IV of this dissertation. 
The overall purpose of this body of work has been to conduct basic 
research into efflux pump inhibition, improving methods for the study of this 
phenomenon and producing information valuable to understanding the botanical 
context in which it occurs. The first of these goals is of obvious importance to 
medical science, as has been explained previously in this introduction. The latter 
of these goals is of importance to understanding the role efflux pump inhibition 
plays in the plant kingdom. This question is one of importance because it can 
inform a wide array of future studies on the efflux pump inhibitors at many levels, 
including future pharmaceutical research, research into the ecology of plant 
defense mechanisms, and research into human usage of botanical medicines.  
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Table 1.2.  Distribution in the Plant Kingdom of the 4 Example 
Flavonoids, Based on a Review of Existing Literature 
Flavonoid 
aglycone 
Distribution and citations 
Apigenin Chlorophyta, widespread in the bryophytes including both 
liverworts and mosses, Psiloteceae, Lycopodiaceae, 
Selaginellaceae, Isoetaceae, Equisetum, Psilotaceae, 
Pteridopsida ferns, widespread in flowering plants 
(Basile et al.1999, Hiraoka 1978, lwashina 2000, Iwashina et 
al. 2006,Markham et al. 1998, Markham and Porter 1973, 
Miean and Mohamed 2001, Richardson 1989, Salatino and 
Pradoa 1998, Veit et al. 1995, Wallac 1989, Wollenweber 1989) 
Luteolin Liverworts, Mosses, Equisetum, Lycopodiaceae, Pteridopsida 
ferns, widespread in flowering plants 
(Basile et al. 1999, Hiraoka 1978, lwashina 2000, Markham et 
al. 1998, Miean and Mohamed 2001,Richardson 1989, Salatino  
et al. 2000, Salatino and Pradoa 1998, Veit et al. 1995) 
Quercetin Liverworts, mosses, Pteridopsida ferns, Equisetum, 
Psilotaceae, Pinaceae, widespread in flowering plants 
(Chen and Xiao 2005, Hertog et al. 1992, Hiraoka 
1978,Hollman et al. 1997, Kaundun et al. 1998a, 1998b, 
lwashina  2000, Iwashina et al. 1995, 2006, Miean and 
Mohamed 2001,Richardson 1989, Salatino et al. 2000, Salatino 
and Pradoa 1998, Veit et al. 1995, Wallace 1989) 
Kaempferol Mosses, Pteridopsida ferns, Equisetum, Psilotaceae, Pinaceae, 
widespread in flowering plants 
(Hertog et al. 1992, Hiraoka 1978,Kaudun et al. 1998a, 1998b, 
2000, lwashina 2000, Iwashina et al. 1995, 2006, Miean and 
Mohamed 2001, Niemann and Genderen 1980, Richardson 
1989,Salatino et al., 2000, Salatino and Pradoa 1998, Veit et 
al. 1995, Wallace 1989, Wollenweber 1989) 
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CHAPTER II 
 
A MASS SPECTROMETRY-BASED ASSAY FOR IMPROVED QUANTITATIVE 
MEASUREMENTS OF EFFLUX PUMP INHIBITION 
 
 
Note:  This chapter of the dissertation is a paper currently in press with the 
journal Plos One. 
 
Abstract 
 Bacterial efflux pumps are active transport proteins responsible for 
resistance to selected biocides and antibiotics.   It has been shown that 
production of efflux pumps is up-regulated in a number of highly pathogenic 
bacteria, including methicillin resistant Staphylococcus aureus.  Thus, the 
identification of new bacterial efflux pump inhibitors is a topic of great interest.  
Existing assays to evaluate efflux pump inhibitory activity rely on fluorescence by 
an efflux pump substrate.   When employing these assays to evaluate efflux 
pump inhibitory activity of plant extracts and some purified compounds, we 
observed severe optical interference that gave rise to false negative results.  To 
circumvent this problem, a new mass spectrometry-based method was 
developed for the quantitative measurement of bacterial efflux pump inhibition.  
The assay was employed to evaluate efflux pump inhibitory activity of a crude 
extract of the botanical Hydrastis canadensis, and to compare the efflux pump 
inhibitory activity of several pure flavonoids.  The flavonoid quercetin, which 
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appeared to be completely inactive with a fluorescence-based method, showed 
an IC50 value of 75 µg/mL with the new method.  The other flavonoids evaluated 
(apigenin, kaempferol, rhamnetin, luteolin, myricetin), were also active, with IC50 
values ranging from 19 µg/mL to 75 µg/mL.  The assay described herein could be 
useful in future screening efforts to identify efflux pump inhibitors, particularly in 
situations where optical interference precludes the application of methods that 
rely on fluorescence. 
Introduction 
 Bacterial efflux pumps are active transport proteins that function to extrude 
toxic compounds, including antimicrobial drugs, from the cell.  These pumps 
serve to protect bacteria from damage by toxins, and can play a role in the 
development of resistance to antimicrobials (Bambeke et al. 2000, Brenwald et 
al. 1998,Saidijam et al. 2006, Tegos et al. 2002,Yin et al. 2006).  For example, it 
has been shown that production of efflux pumps is up-regulated in drug resistant 
strains of many bacteria, including methicillin resistant Staphylococcus aureus  
(Junio et al. 2011,Piddoc 2006a, 2006b, Stermitzet al. 2000b,Walsh 2000).  
Compounds that inhibit bacterial efflux pumps are of interest because of their 
potential to increase antimicrobial effectiveness (Simões et al. 2009).  Thus, our 
laboratory has been engaged in experiments to find new efflux pump inhibitors 
(EPIs) from natural product sources.   
 Current methods for evaluating efflux pump inhibitory activity rely on an 
efflux pump substrate that fluoresces only when it is located inside a cell (due to 
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intercalation with DNA) (Olmsted and Kearns 1977).  The majority of existing 
protocols operate by pre-loading cells with the efflux pump substrate ethidium 
bromide, which gives them a high initial fluorescent intensity.  The extent of efflux 
pump inhibition is then measured by comparing the rate of decrease in 
fluorescence intensity over time in the presence of varying amounts of the 
putative EPI (Ettefagh et al. 2011, Kaatz et al. 2000, Lechner et al. 2008,Pereda-
Miranda et al. 2006, Sabatini et al. 2008, Schindler et al. 2013, Stermitz et al. 
2000,Tegos et al. 2002).  Related experiments utilizing measurements based on 
the intracellular accumulation of fluorescent substrates have also been reported 
(Mahamoud et al. 2006, Stermitz et al. 2000b).  For accumulation experiments, 
fluorescence increases over time as the substrate diffuses into cells.   
 Ethidium bromide is attractive as a substrate for assaying efflux pump 
inhibition because of extensive literature precedent of its application in efflux 
inhibition assays (Ettefagh et al. 2011, Kaatz et al. 2000, Lechner et al. 
2008,Pereda-Miranda et al. 2006, Sabatini et al. 2008, Schindler et al. 2013, 
Stermitz et al. 2000,Tegos et al. 2002).  This compound has also been 
established to be active via intracellular action, with literature precedent 
stretching back to the 1950’s (Newton 1957,Olmsted and Kearns 1977, Waring 
1965).  However, the existing methods for testing efflux pump inhibition with 
ethidium bromide gave false results in our study due to matrix quenching effects 
(the suppression of fluorescence by various components of the mixture) in crude 
extracts and even with some pure compounds. We endeavored to circumvent 
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these quenching effects by developing a new mass spectrometry-based efflux 
pump inhibition assay.  There is extensive literature support for the efflux pump 
inhibitory activity of flavonoids and related compounds (Ettefagh et al. 2011, 
Gibbons 2004, 2005, Guz et al. 2001, Hamilton-Miller and Shah 2000, Junio et 
al. 2011, Simões et al. 2009, Stavri et al. 2007,Stermitz et al. 2000a, 
2000b,Stermitz et al. 2001, Stermitz et al. 2002).  Thus, we sought to validate the 
new assay by comparing efflux pump inhibitory activity of a series of pure 
flavonoids.  In addition, to test the validity of the new assay in a more crude 
sample matrix, we compared the efflux pump inhibitory activity of an extract from 
the botanical goldenseal (Hydrastis canadensis), which is known to contain EPIs 
(Ettefagh et al. 2011, Junio et al. 2011), using both fluorescence and mass 
spectrometry-based approaches for data collection.   
Materials and Methods 
Preparation of plant material 
 The goldenseal leaf and petiole material used was cultivated in a 
woodland setting in Hendersonville, North Carolina, (N 35°24.2770', W 
082°20.9930', 702.4 m elevation) and was made available by William Burch; this 
population has been utilized in previously published work (Ettefagh et al. 2011, 
Junio et al.2011) and is represented by a voucher (NCU583414) curated in the 
University of North Carolina at Chapel Hill herbarium.  The goldenseal extract 
was prepared using previously described methods (Gu et al. 2004, Junio et 
al.2011).  Dried plant material was macerated for at least 24 hr, and the methanol 
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extract was subsequently separated from the plant material.  This extract was 
dried in a rotary evaporator to reduce the volume of methanol, and partitioned 
against an equal volume of hexane.  The resulting mixture was stirred for at least 
one hr and the layers were collected separately using a separatory funnel.  The 
methanol partition was added to water and chloroform in a ratio of 1:5:4, stirred 
for at least 1 hr, then separated.  The chloroform partition from this step was 
evaporated and used as the starting material for all experiments described 
herein, and will be referred to as “goldenseal extract” from this point forward. 
96 well plate ethidium bromide accumulation assay 
 This assay is an adaptation of published ethidium bromide efflux-based 
assays (Ettefagh et al. 2011, Kaatz et al. 2000,Schindler et al. 2013) and 
previously published reports of measurements on intracellular accumulation of 
berberine and chloramphenicol (Mahamoud et al. 2006, Stermitz et al. 2000b).  
All experiments presented here were performed in the 96 well plate format.  
Activity was tested using Staphylococcus aureus strain NCTC 8325-4 (Novick 
1967).  The final assay composition was 10% DMSO, 50% Muller-Hinton broth, 
40% water (by volume), an estimated 1.6-1.8x108 CFU/mL S. aureus, 1.25 µg/mL 
ethidium bromide, and a range of analyte concentrations.  Data collection, and 
hence bacterial exposure to these conditions, was limited to 30 min.  The alkaloid 
piperine was used as a positive control, as it is well established in the literature to 
be an EPI (Khan et al. 2006,Nargotra et al. 2009, Stavri et al. 2007).  Each 
analyte concentration was tested in triplicate, and the positive control (a piperine 
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dilution series ranging from 4.7 µg/mL to 300 µg/mL prepared via 2-fold dilution) 
was included on each plate.  Fluorescence was measured using a BioTek 
SynergyH1 microplate reader (BioTek, Winooski, VT) with an excitation 
wavelength of 520 nm and emission wavelength of 600 nm at 1 min intervals for 
a total of 30 min.  All experiments were performed in triplicate and vertical bars 
reported as standard deviation. 
Use of mass spectrometry to measure ethidium bromide accumulation 
 To enable mass spectrometric measurements of ethidium bromide 
accumulation, the experimental parameters were identical to those described in 
the previous section, except that the method of data collection was modified.   
The prepared samples were incubated at room temperature in a EMD Millipore 
MultiScreen™ fritted-bottom 96-well filter plate (pore size 0.22 µm, EMD 
Millipore, Darmstadt, Germany).  At the conclusion of the 30 min incubation 
period, these were filtered simultaneously under vacuum into a receiving 96 well 
plate.  All solutions were stored at 4 ºC  prior to analysis. 
 Ethidium bromide in the bacterial supernatant was analyzed using high 
performance liquid chromatography (HPLC) electrospray ionization-mass 
spectrometry (ESI-MS).  Liquid chromatography separations were achieved 
using a ThermoFinnigan Surveyer HPLC system (Thermo Finnigan, San Jose, 
CA).  The autosampler was temperature controlled at 8 oC, and the column 
(Agilent Prevail C18, 3 μm packing, 50 x 2.1 mm) was heated to 40 oC.  Sample 
injection volume was 5 µL and a flow rate of 0.2 mL/min was employed.  
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Samples were eluted using binary gradients consisting of acetonitrile acidified 
with 1% acetic acid and deionized water  (CH3CN:H2O) as follows:— 0 min, 
0:100; 1.5 min, 0:100; 2 min, 95:5; 10 min, 95:5; 10.5 min, 0:100; 18 min, 0:100.  
Mass spectrometry analyses were conducted with an LCQ DECA XP Plus ion 
trap mass spectrometer with electrospray ionization source (Thermo Fisher 
Scientific) using the following conditions: capillary temperature, 250 oC; sheath 
gas flow, 10 (arbitrary units); no auxiliary gas; source voltage 4.5 kV; capillary 
voltage, 42 V; tube lens offset, -25 V.  The instrument was operated in the 
positive ion mode with two scan events.  The first was full scan, followed by the 
data-dependent CID fragmentation (50% collision energy) of m/z 314.20 (the [M]+ 
ion of ethidium). The selected ion chromatogram was plotted for the main product 
ion m/z 286, and its peak area was determined.  All experiments were performed 
in triplicate and vertical bars set to standard deviation. 
 Mass spectrometry data were analyzed to determine an IC50 value for 
each test compound. The IC50 of piperine was defined as the midpoint between 
the peak area for vehicle control and that of the 300ppm piperine sample, similar 
to an approach employed previously [42].  Once determined for piperine, the 
same peak area was used as a set point for determining IC50 values of the test 
compounds on the same plate.   
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Bacterial growth inhibition 
 Minimum inhibitory concentrations (MICs) were determined according to 
Clinical Laboratory Standards Institute guidelines (Wikler et al. 2006).  Solutions 
were prepared in 96 well plates with a final well volume of 250 µL, 2% DMSO in 
Mueller-Hinton broth, and variable concentrations of test compound or extract 
ranging from 4.7 to 150 µg/mL, prepared in triplicate.  Duplicate plates of each 
experiment were employed, one inoculated with a bacterial concentration of 
5x105 CFU/mL, the other containing only analyte and vehicle.  All plates were 
incubated for 18 hr at 37 oC, after which turbidity at 600nm (OD600) was 
measured with a BioTek SynergyH1 microplate reader.  To correct for background 
due to absorbance of the analyte compounds, the mean OD600 for each 
treatment without addition of bacteria was subtracted from the mean OD600 of 
treated wells.  MIC was determined as the concentration where there was no 
statistically significant difference between the mean absorbance of the treated 
wells and that of the negative control (vehicle in broth). 
Results and Discussion 
Assay development and comparison of efflux pump inhibition assay methods 
 The first goal of our experiments was to determine the applicability of a 
fluorescence-based accumulation assay to measure the efflux pump inhibitory 
activity of various flavonoids.  Towards this goal, we first validated the assay 
using a known efflux pump substrate (ethidium bromide) and a known EPI 
(piperine).  As expected, when S. aureus is exposed to ethidium bromide, 
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fluorescence increases over time (Figure 2.1).  This increase is due to 
intracellular accumulation of ethidium, which fluoresces at 600 nm when it is 
intercalated with DNA (Ettefagh et al. 2011).  Ethidium bromide is a substrate of 
NorA, a major chromosomally-encoded Staphylococcus aureus efflux pump 
(Bambeke et al. 2000, Saidijam et al. 2006).  Thus, the intracellular accumulation 
of ethidium bromide by S. aureus is counteracted by the action of NorA (and 
other efflux pumps).  As evidence of this, the addition of piperine, a known NorA 
inhibitor, caused a more pronounced increase in fluorescence over time than was 
observed for the cells in the absence of the inhibitor (Figure 2.1).   
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Figure 2.1.  Change in Absolute Fluorescent Intensity Over Time for Staphylococcus 
aureus Exposed to Ethidium Bromide and the Efflux Pump Inhibitor Piperine. 
Fluorescence increases over time due to intracellular accumulation of ethidium bromide.  
The increase is more pronounced in the presence of piperine, which enhances 
intracellular accumulation of ethidium bromide by blocking efflux.  Data points represent 
the mean of 3 samples, vertical bars represent standard deviation. 
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Figure 2.2. Change in Fluorescence Due to Ethidium Accumulation by S. aureus in 
the Presence of Putative Inhibitors.  (A) Dose-response curves for the flavonoids 
apigenin and quercetin.  (B) Fluorescence observed for 150 µg/mL piperine in the 
presence of increasing concentrations of quercetin. Decrease in fluorescence with 
increasing quercetin concentration in (B) can be attributed to fluorescence quenching by 
the flavonoid.  Data points represent the mean of triplicate measurements (biological 
replicates), vertical bars represent standard deviation. 
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Figure 2.3. Representative Selected Chromatograms of Filtered, Spent Broth 
Showing a Peak for the Ethidium Ion (MS-MS Transition of m/z 314 to 286). 
Sample 1 is the negative control (S. aureus cultured for 30 min in Mueller Hinton broth 
with 1.25 µg/mL ethidium bromide and 10% DMSO).  Samples 2 and 3 were cultured 
under the same conditions as sample 1 with the addition of 75 µg/mL and 300 µg/mL 
piperine, respectively.  All three peaks are normalized to a signal intensity of 3.45 x 106.  
As piperine is added, efflux pumps are blocked, trapping the ethidium inside the cells 
and decreasing the quantity of ethidium (as indicated by the area of the ethidium peak) 
in the spent broth.   
 
 
To circumvent the problem with optical matrix interference, a method was 
developed using liquid chromatography - mass spectrometry (LC-MS) to 
measure ethidium bromide concentrations in the spent broth filtrate.  The 
concentration-response relationship for the data generated by the LC-MS method 
was expected to be the inverse of that generated by the measurement of 
fluorescence—as the concentration of an inhibitor increases, it traps the ethidium 
inside the bacterial cells, and the concentration of ethidium in the spent broth 
filtrate (as measured by LC-MS) should decrease.   
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Figure 2.4.  Efflux Pump Inhibitory Activity of 6 Flavonoids (Luteolin, Quercetin, 
Apigenin, Myricetin, Rhamnetin and Kaempferol) Compared to that of Piperine, as 
Indicated by LC-MS Measurement of Residual Ethidium Bromide in Spent Broth 
After a 30 Min Incubation. 
Relative peak area (expressed as a percentage) for ethidium is plotted as a function of 
concentration of the putative inhibitor.  Data points represent the mean of 3 
measurements (biological replicates), with vertical bars representing standard deviation.  
Rhamnetin was only prepared at concentrations up to 150 µg/mL due to solubility 
problems. Panels A and B represent data taken from two different 96 well plates, 
generated via the same method. 
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The known EPI piperine was again used for assay validation and it was observed 
that, as expected, the concentration of ethidium in the filtrate decreased with 
increasing concentration of piperine (Figure 2.3).  These results were plotted in a 
dose-response curve, with peak area displayed on the y-axis and concentration 
on the x-axis (Figure 2.4).   
With the LC-MS assay, it is possible to quantify the extracellular levels of 
ethidium without relying on fluorescence.  Thus, if quercetin is in fact an active 
EPI and the negative results observed in the fluorescence based assay (Figure 
2.2) are due to quenching, quercetin should have demonstrable activity in the 
new LC-MS based assay.   Consistent with this expectation, the LC-MS based 
method showed quercetin to be active as an EPI (Figure 2.4).  Once the 
confounding effect of quenching is removed, it is apparent that quercetin is 
similar in its EPI activity to piperine, and apigenin is the most active EPI of the 
three. Furthermore, the LC-MS method showed a more typical dose-response 
relationship for apigenin (Figure 2.4) compared to the fluorescence-based assay 
(Figure 2.2A), suggesting that apigenin quenches ethidium fluorescence at 
concentrations ≥ 38 µg/mL.   
To further evaluate the applicability of the LC-MS based efflux pump 
inhibition assay, we measured IC50 values (Table 2.1) for a series of six 
structurally diverse flavonoids and the aforementioned compound piperine.  All 
six flavonoids were active (sample data shown in Figure 2.4), with IC50 values 
ranging from 19 µg/mL (kaempferol and rhamnetin) to 75 µg/mL (quercetin, 
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luteolin, and myricetin.)  (Table 2.1).  Piperine demonstrated an IC50  value in this 
assay between 75 µg/mL and 150 µg/mL. 
Finally, it was of interest to evaluate whether the mass spectrometry-
based efflux assay would be applicable to samples with more complex matrices.  
Toward this goal, a botanical extract prepared from goldenseal (Hydrastis 
canadensis) was evaluated for EPI activity using both the fluorescence-based 
and mass spectrometry-based ethidium bromide accumulation assays.  When 
assayed by the fluorescence-based method, the extract appeared inactive (no 
apparent IC50, Figure 2.5A), contradicting literature that indicates H. canadensis 
extracts contain EPIs (Ettefagh et al. 2011, Junio et al. 2011).  However, when 
the activity of the extract was evaluated with the mass spectrometry-based 
assay, an IC50 value of 75 µg/mL was observed (Figure 2.5B).   These results 
demonstrate that quenching can hamper the measurement of efflux pump 
inhibition for complex extracts using fluorescence, and that the interference can 
be overcome using the method developed herein.   This finding is particularly 
important given that it may be useful in drug discovery efforts to screen complex 
extracts for the presence of EPIs. 
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Figure 2.5. Efflux Pump Inhibition in S. aureus by a Goldenseal (Hydrastis 
canadensis) Extract. 
Data collected using the fluorescence-based ethidium accumulation assay for a range of 
H. canadensis extract concentrations.  (B) Data collected using the mass spectrometry-
based ethidium accumulation assay.  Incubation time was 30 min for both A and B, data 
represents mean of 3 samples, vertical bars represent standard deviation. Note, 
bacterial growth was less vigorous in this assay (Figure 2.5) as compared to Figures 2.1 
and 2.2, which is reflected in the lower overall fluorescence values. 
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Table 2.1.  Efflux Pump Inhibitory Activity and Antimicrobial Activity of 
Flavonoids 
Flavonoid IC50 for efflux inhibitiona MICb 
Apigenin 38 µg/mL (140 µM) >150 µg/mL (>560 µM) 
Kaempferol 19 µg/mL (66.0 µM) >150 µg/mL (>520 µM) 
Rhamnetin 19 µg/mL (60.0 µM) >150 µg/mL (>470 µM) 
Quercetin 75 µg/mL (250 µM) >150 µg/mL (>500 µM) 
Luteolin 75 µg/mL (260 µM) 75 µg/mL (260 µM) 
Myricetin 75 µg/mL (240 µM) 150 µg/mL (470 µM) 
a. Efflux pump inhibition was measured via LC-MS analysis of ethidium in spent, filtered 
culture supernatant after a 30 min incubation in triplicate wells. 
b. Growth inhibition was measured by optical density at 600nm (in triplicate) after an 18 
hr incubation. 
  
 
Potential interference by growth effects 
 Many botanical compounds possess antimicrobial activity.  Thus, it was 
important to evaluate whether growth effects might confound the measurements 
of efflux pump inhibition.  Towards this goal, the flavonoids and the goldenseal 
extract were screened for inhibition of bacterial growth across a range of 
concentrations, from 4.7 µg/mL to 150 µg/mL.  Only two samples (the flavonoids 
luteolin and myricetin, Table 2.1) demonstrated measureable MICs under these 
conditions.  To determine whether growth inhibition by these compounds was 
likely to confound data interpretation, the two inhibitory flavonoids (luteolin and 
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myricetin) were incubated with test strains under the experimental conditions at 
twice their IC50 values (Table 2.1).  S. aureus cells were tested for loss of viability 
in the presence of these flavonoids (as well as in the presence of the flavonoid 
apigenin which does not inhibit bacterial growth) by replicating the experimental 
conditions of bacterial, ethidium bromide, broth and DMSO content, and plating 
aliquots of the resulting culture onto supplemented Mueller-Hinton agar at 0, 15 
and 30 min time points.  No loss of viability was observed after a 30 min 
exposure to the experimental conditions, as determined by colony count 
enumeration (Figure 2.6).  Additionally, to further evaluate the potential for simple 
toxicity to confound evaluation of data in this assay, the commercial antibiotics 
gentamicin and nafcillin were subjected to the mass spectrometry-based efflux 
pump inhibition assays, and no IC50 was observed to the maximum concentration 
tested of 100 µg/mL (Figure 2.7). The highest tested concentration for the 
antibiotics was well above their reported MICs against Staphylococcus aureus 
(~0.5 µg/mL (LaPlante and Rybak 2004, Mulazimoglu et al. 1996)).  Collectively, 
these results suggest that growth inhibition does not confound  the 
measurements of efflux pump inhibitory activity reported in Table 2.1. 
 In light of the health risks posed by the increased occurrence of antibiotic  
 
resistant bacterial strains, the need for reliable methods for their study is of high  
 
importance.  The mass spectrometry-based method to quantitatively investigate  
 
efflux pump inhibition is just such a tool, and as such is expected to be of high  
 
value to the scientific community.  Our study shows that misleading results (false   
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negative in the case of assays that rely on ethidium bromide accumulation) can  
 
be obtained when screening crude extracts and even pure compounds with  
 
fluorescence-based efflux pump inhibition assays.  The new method presented  
 
here circumvents these problems.  Additionally, the ubiquity of activity in the  
 
flavonoids tested in the validation process of this assay reinforces the importance  
 
of this class of natural products in the reversal of efflux-pump mediated drug  
 
resistance. 
 
 
 
 
Figure 2.6. Time Series Data Evaluating the Viability of Staphylococcus aureus 
Cultures Exposed to Experimental Conditions. 
Conditions are as follows: 10% DMSO, 50% Muller-Hinton broth, 40% water (by 
volume), with 1.25 µg/mL ethidium bromide, for a maximum of 30 min.  Test compounds 
include two flavonoids that inhibit the growth of this strain (luteolin and myricetin), and 
one that does not (apigenin) (Table 2.1). Two-tail T-test values comparing the 0 and 30 
minute time points are as follows: apigenin, p= 0.15; luteolin, p= 0.16; myricetin, p= 0.95.  
Thus, no statistically significant changes at the 95% confidence interval were observed 
in cell viability. 
31 
 
 
 
Figure 2.7. Efflux Pump Inhibitory Data Generated Via the Mass Spectrometry-
Based Assay Performed on the Known Antibiotic Compounds Gentamicin and 
Nafcillin. 
Also shown is a control dose-response curve performed on the positive control piperine. 
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Abstract 
Secondary metabolites play a critical role in plant defense against disease.  
One important example of this is the interaction between plant antibiotic 
secondary metabolites and other metabolites that inhibit bacterial efflux pumps.  
Bacterial efflux pumps are active transport proteins that bacterial cells use to 
protect themselves against multiple toxic compounds, including many 
antimicrobials.  Plant efflux pump inhibitors can block these efflux pumps, 
rendering antimicrobial compounds more effective as defense molecules than 
they otherwise would be.  The goal of this research was to employ a recently 
developed mass spectrometry-based assay to evaluate the distribution of efflux 
pump inhibitors in fourteen plant extracts spanning the important land plant 
lineages (two bryophytes, five pteridophytes, three gymnosperms, and four 
angiosperms).  For these studies, Staphylococcus aureus was used as a test 
bacterium.  Efflux pump inhibitory activity was observed in extracts from all but 
four species (Nephrolepis exaltata, Ginkgo biloba, Cycas circinalis, and 
Glaucidium palmatum).   The most active extracts were those prepared from 
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Osmunda claytoniana and Pinus strobus, which both demonstrated IC50 values 
for efflux inhibition of 19 ppm. Our results indicate that efflux pump inhibitors are 
common in land plants and that they appeared early in the evolutionary history of 
land plants. 
Introduction 
Understanding plant defense against bacterial infection is a vital 
component to the study of plant evolution and ecology.  One very interesting 
plant defense mechanism is the production by plants of bacterial efflux pump 
inhibitors (Stermitz et al. 2000b).  Efflux pumps are active transport proteins 
located in bacterial cell membranes. Bacteria use the pumps to export, or expel, 
toxins that enter from the bacterial environment.  Efflux pump inhibitors block the 
function of these pumps, causing intracellular accumulation of toxic compounds.  
It has been proposed that the presence of bacterial efflux pump inhibitors may 
partially explain the efficacy of botanical medicines traditionally used to treat 
infection (Tegos et al. 2002).  Efflux pump inhibitors may also play an important 
role in plant evolution (Pieterse and Dicke 2007, Treutter 2005).  For example, 
certain plants have been shown to produce a mixture of antimicrobial compounds 
(substrates for efflux pumps) and efflux pump inhibitors that synergistically 
enhance the efficacy of the antimicrobials (Junio et al. 2011, Stermitz et al. 
2000b).  Plants produce a large number of secondary metabolites with little or no 
known activity or usefulness.  The reason for this continues to be something of 
an evolutionary quandary, and has been for some time (Jones and Fern 1991).  
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The presence of efflux pump inhibitors could shed light on at least one aspect of 
this issue, and on the evolution and ecology of plant defense against infection.   
 Plant extracts and secondary metabolites that inhibit bacterial efflux 
pumps are also of interest because of their potential to increase human relevant 
antimicrobial effectiveness (Simões et al. 2009). Over-production of efflux pumps 
is one mechanism by which bacteria have evolved antibiotic resistance 
(Brenwald et al. 1998, Saidijam et al. 2006, Yin et al. 2006).   Thus, efflux pump 
inhibitors are being studied as potential therapeutics against drug-resistant 
bacterial infections (Lomovskaya and Bostain 2006), and investigations aimed at 
identifying new efflux pump inhibitors have potential to be of relevance not only to 
ecology and plant evolution, but also to medical research. 
 A number of studies have focused on identifying bacterial efflux pump 
inhibitors from natural sources (Gibbons 2005, Hemaiswarya et al. 2008, Simões 
et al. 2009, Tegos et al. 2002). Literature shows that efflux pump inhibitors are 
widely distributed in angiosperms, occurring in at least 25 genera.  Among the 
reported efflux pump inhibitors from botanicals, the flavonoid chemical class is 
particularly prominent (Abulrob et al. 2004, Belofsky et al. 2004, 2006, Brenwald 
et al. 1998, Chérigo et al. 2009, Gibbons et al. 2003, Gibbons 2004, 2005, Guz et 
al. 2001, Ettefagh et al. 2011, Hamilton-Miller and Shah 2000,  Junio et al. 2011, 
Khan et al. 2006, Marquez et al. 2005, Michalet et al. 2007, Morel et al. 2003, 
Nargotra et al. 2009, Oluwatuyi et al. 2004, Simões et al. 2009, Stavri et al. 2007, 
Stavri et al. 2007, Stermitz et al. 2000a, 2000b, 2001, 2002, 2003).  Additionally, 
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there are two reports which mention the efflux inhibitory activity of the 
gymnosperm Chamaecyparis lawsoniana and its essential oils (Smith et al. 
2007a, 2007b). However, mention of efflux pumps in plants more primitive than 
the gymnosperms is lacking in the literature.   The flavonoid chemical family 
(beginning with the most primitive aglycones apigenin and luteolin) is both shared 
between and localized to the land plant lineage (Buer et al. 2010, Crawford 1978, 
Harborn 1977, lwashina 2000, Kaundun et al. 1998, Markham and Porter 1969a,  
Richardson 1989,  Wiedenfeld et al. 2000) and its sister group of green algae, 
order Charales (Becker and Marin 2009, Delwiche et al. 2002, Garbary et al. 
1993,  Lwashina 2000, Markham and Porter 1969b, Stafford 1991).  Additionally, 
the flavonoids apigenin and luteolin, which are produced by many species, are 
efflux pump inhibitors (Brown et al. 2015).  In light of this, and the observation of 
efflux pump inhibitory activity in C. lawsoniana (Smith et al. 2007a, 2007b), it 
stands to reason that bacterial efflux pump inhibitor production is likely to be 
more widely distributed than just the flowering plants that dominate the literature.  
Thus, we hypothesized for this study that the ability to produce efflux pump 
inhibitors developed early in the evolution of land plants.  To test this hypothesis, 
we measured the efflux pump inhibitory activity of extracts from a series of plants 
from various branches of this lineage, and we quantified known efflux pump 
inhibitory flavonoids in these plant extracts. 
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Materials and Methods 
Collection and preparation of plant material 
The species of land plants used for the study sampled all major groups of 
land plants (Fig 1). Plant material was acquired via wild collections, cultivation, or 
purchase. Wild-collected material was obtained from private property 
(Pennsylvania, United States of America) with permission of the land owner and 
from the campus of the University of North Carolina Greensboro. No protected 
species were collected.  A voucher specimen representing each collection was 
preserved and deposited at the UNC herbarium (see voucher numbers in Table 
1).  The plant material was cleaned of debris and air-dried until crisp.  Only the 
aerial portions of each plant were used except in the case of Marchantia sp., for 
which the whole plant was used because of its small size. 
 Plant extracts were prepared according to previously described extraction 
methods (Gu et al. 2004, Junio et al. 2011).  For each plant species, dried plant 
material was macerated in methanol for at least 24 hr, and the liquid extract was 
subsequently separated from the solid material via vacuum filtration.  This 
procedure was repeated three times, and all three extracts from one batch of 
plant material were combined and partitioned using an equal volume of hexane.  
This mixture was then stirred for at least one hr, and the methane/hexane layers 
were collected using a separatory funnel.  The methanol partition was added to 
water and chloroform in a ratio of 1:5:4, stirred for at least 1 hr, and then 
separated.  The chloroform partition was evaporated and used as the starting 
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material for all experiments described herein, and will be referred to as “plant 
extract” from this point forward. 
Determination of efflux pump inhibitory activity 
 Standard methods for measuring efflux inhibition rely on ethidium bromide-
based fluorescence assays  (Ettefagh et al. 2011, Kaatz et al. 2000, Lechner et 
al. 2008, Pereda-Miranda 2006, Sabatini et al. 2008, Schindler et al. 2013, 
Stermitz et al. 2000B, Tegos et al. 2002).  Consistent with a recent report from 
our laboratory (Brown et al. 2015), we observed severe quenching effects with 
fluorescence based methods of evaluating efflux pump inhibition for the plant 
extracts studied herein (data not shown).  To circumvent interference due to 
fluorescence quenching, we employed a recently developed liquid 
chromatography-mass spectrometry (LC-MS) based assay as an alternative 
approach for measuring efflux pump inhibitory activity.  Rather than attempting to 
measure activity by fluorescence, the quantity of ethidium ion remaining in the 
filtered spent broth from S. aureus cultures was measured using LC-MS.   The 
presence of an efflux pump inhibitor causes ethidium to accumulate inside the 
bacterial cells, with the result that the concentration of ethidium measured in the 
spent broth decreases as inhibitor concentration increases.  Thus, efflux pump 
inhibition was evaluated via a mass spectrometry-based assay as described 
previously (Brown et al. 2015).   
Plant extracts were tested by micro dilution in 96 well plates, prepared via 
2-fold serial dilution at a range of concentrations from 300 µg/mL to 4.7 µg/mL.  
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The vehicle composition was 50% Mueller-Hinton broth [containing a culture of 
Staphylococcus aureus strain number NCTC 8325-4 (Novick 1967) grown to an 
OD600 of 0.7-0.9], 40% deionized water, and 10% DMSO (by volume) with the 
addition of 1.25 µg/mL ethidium bromide.  The approximate final reaction 
concentration of bacteria was 1.6-1.8 × 108 CFU/mL.  Bacteria were incubated at 
the above conditions for 30 min, and then removed via filtration with an EMD 
Millipore MultiScreen™ fritted-bottom 96-well filter plate (pore size 0.22 µm, EMD 
Millipore, Darmstadt, Germany).  Residual ethidium bromide was analyzed in the 
spent broth via an LC-MS method as described in (Brown et al. 2015), and the 
data were plotted as dose-response curves of ethidium peak area versus 
inhibitor concentration.  IC50 values were calculated from the dose-response 
curves as described previously (Brown et al. 2015).   
Evaluation of bacterial growth inhibition 
 The  minimum inhibitory concentration (MIC) was evaluated for all plant 
extracts against Staphylococcus aureus used in this study in accordance with 
Clinical Laboratory Standards Institute (CLSI) methods (Wikler et al. 2006).  
Briefly, a 24 hr single-colony seed culture of Staphylococcus aureus NTCC 8325-
4 was grown to log phase and diluted such that the final starting reaction 
concentration of bacteria was 5 ×105 CFU/mL.  The final reaction mixture was 
250 µL composed of 2% DMSO, 98% Mueller-Hinton broth, and varying 
concentrations of a given test extract (ranging from 150 µg/mL to 4.7 µg/mL, 
prepared via serial dilution)  in 96-well plates.  A duplicate plate without bacteria 
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was also prepared to establish the background absorbance of the samples.  All 
samples were incubated for 18 hr at 37 oC, and absorbance was measured with 
a BioTek SynergyH1 microplate reader (Winooski, VT, USA) at 600nm.  The 
optical density from the background plate was subtracted from that of the test 
plate and the data plotted graphically to determine minimum inhibitory 
concentrations (MICs).   
Identification and quantitation of flavonoids in plant extracts 
 An Aquity UPLC (Waters) coupled to a Q Exactive Plus mass 
spectrometer (Thermo Scientific) was employed for quantitative analyses of six 
flavonoids found in our previous studies to be active efflux pump inhibitors 
(Brown et al. 2015).  The instrument conditions were as follows: capillary 
temperature, 310 oC; sheath gas flow, 25 (arbitrary units); auxiliary gas, 5 
(arbitrary units); source voltage 3.7 kV; HESI probe temperature, 50oC; S lens, 
50; scan range 250 m/z—325 m/z in the positive mode.  Separation was 
achieved with a 2.1 × 50 mm Acquity UPLC BEH shield C18 column with 1.7 µM 
particle size operated at a column temperature of 40 oC.  The solvent was 
comprised of acetonitrile with 0.1% formic acid and deionized water with 0.1% 
formic acid at a flow rate of 0.3 mL/min.  The 10 min gradient employed the 
following ratios (CH3CN:H2O):— 0 min., 10:90; 5 min., 50:50; 6 min, 50:50; 7 
min., 60:40; 7.5 min., 60:40; 8 min., 70:30; 8.5 min., 100:0; 9 min., 100:0; 9.5 
min., 10:90; 10 min., 10:90 (Junio 2011).  Flavonoids were identified by accurate 
mass and comparison of retention time with standards, and quantified using 
40 
 
linear regression by comparing peak area of flavonoids in plant extracts to 
external calibration curves for the relevant standards. 
Results and Discussion 
The hypothesis tested in this study is that the ability to produce efflux 
pump inhibitors developed early in the evolution of land plants.  This hypothesis 
is supported by the finding that many extracts tested here are active efflux pump 
inhibitors, including extracts from one gymnosperm (Pinus strobus) four 
pteridophytes (Diphasiastrum digitatum, Osmunda claytoniana, Equisetum 
hyemale, Psilotum nudum) as well as both bryophytes Marchantia spp. and 
Sphagnum spp (Table 3.1).  Sample data showing this effect are shown in Fig 
3.2A and 3.2B for the positive control piperine, a known efflux pump inhibitor 
(Khan et al. 2006, Nargotra et al. 2009, Stavri et al. 2007).  Also as indicated in 
Fig 3.2A and 3.2B, a clear dose-response curve was obtained for the botanical 
extracts of P. strobus and D. digitatum using the mass spectrometry-based 
assay.  Thus, bacterial efflux pump inhibitory activity is a common phenomenon, 
and it is more parsimonious to assume it to be of great antiquity than it would be 
to assume it evolved multiple times in recent geological history.  This conclusion 
is congruent with the previously reported findings that the flavonoids, apigenin 
and luteolin, are efflux pump inhibitors (Brown et al. 2015) that evolved prior to 
land plants (Lwashina 2000).  The  majority of the plant extracts investigated 
demonstrated efflux pump inhibitory activity (Table 3.1), with the most active 
being the Osmunda claytoniana and Pinus strobus extracts (IC50 values of 19 
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ppm).  Extracts from four species, Nephrolepis exaltata, Ginkgo biloba, Cycas 
circinalis and Glaucidium palmatum, showed no activity.  Only one sample, the 
extract of Marchantia spp. (Table 3.2) had a measurable MIC under the study 
conditions.  Notably, it has been previously shown (Brown et al. 2015) that the 
occurrence of a growth inhibition is not likely to introduce an artifact into data 
generated via this method, and thus the growth inhibition caused by the 
Marchantia spp. Extract is not likely to be problematic in data interpretation.   
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Figure 3.1. Dendrogram Depicting the Major Lineages of Land Plants and which 
Species Extracted in this Study Belong to Each.   
These assignments are supported by the following sources: Aagaard et al. 2009, 
Bhattacharya and Medlin 1998, Wang and Chen 2007, Wang et al. 2007, Qiu et al. 2007, 
Wikstromand  Kenrick 2000. 
 
 
 High resolution mass spectrometry analysis indicated the presence of 
flavonoids in all but one (Glaucidium palmatum) of the fourteen plant extracts 
tested.  In all extracts, the flavonoids were present at levels below their individual 
IC50 values for efflux pump inhibition of S. aureus (Table 3.1).  As an example, at 
the IC50 concentration of Podophyllum  peltatum (75 µg/mL), the assay 
concentration of kaempferol was 2.4 × 10-1 µg/mL (Table 3.1).  This well below 
the IC50 value for pure kaempferol, which was reported to be 19 µg/mL (Brown et 
al. 2015).  The before mentioned concentration of kaempferol was the highest 
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observed concentration of a flavonoid in this study.  Also, kaempferol along with 
rhamnetin (which also showed an IC50 value of 19 µg/mL [Brown et al. 2015]) 
were the most active flavonoids in this study, all others have activities ranging 
from 38 µg/mL to 75 µg/mL (Brown et al. 2015).  Thus, even in extracts with 
multiple detectable flavonoids, the combined activity of these compounds is not 
sufficient to appreciably contribute to the activity of the extract.  These data 
demonstrate that the individual flavonoids quantified herein are only partially (if at 
all) responsible for the overall efflux pump inhibitory activity of the complex 
botanical extracts, and that it is not possible to definitively link their presence to 
the activity of the extracts.  When considering these data, it is worth noting that 
numerous possible classes and derivatives of flavonoids have been shown to be 
present in botanical extracts, including flavones, isoflavones and flavonols 
(Gibbons 2004, 2005, Stermitz et al. 2002), gallic acid substituted flavonoids 
(Guz et al. 2001, Hamilton-Miller and Shah 2000, Simões et al. 2009, Stavri et al. 
2007), flavolignans (Gibbons 2004, 2005, Guz et al. 2001, Stavri et al. 2007, 
Stermitz et al. 2000a, 2000b, 2001), and other similar phenolic compounds 
(Belofsky et al. 2004, 2006, Stavri et al. 2007).  It is possible that these flavonoid 
derivatives (alone or in combination with other chemical classes) are at least 
partially responsible for the combined efflux pump inhibitory activity of the 
extracts.  Ultimately, more data are needed to clearly elucidate the specific role 
flavonoids and their derivatives play in the efflux pump inhibitory activity of 
modern plants.  
44 
 
 
Figure 3.2. Sample Data Showing Dose Response Curves for Efflux Pump 
Inhibition by the Botanical Extracts Pinuss trobus (A) and Diphasiastrum 
digitatum (B) Collected with Mass Spectrometry-Based Methods.   
A positive response is indicated by a decrease in extracellular residual concentration of 
ethidium, as indicated by decreased peak area with increasing concentration of the 
putative inhibitor.  The known efflux pump inhibitor piperine is used as a positive control 
in all experiments.  Shown are the means of triplicate measurements and standard 
deviations.  
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 The data presented herein raise several interesting possibilities.  The  
 
commonality of efflux pump inhibitory activity demonstrates that land plants are  
 
rich sources of bacterial efflux pump inhibitors.  Thus, land plants might serve as  
 
research tools or as therapeutic agents.  It appears that many botanical extracts  
 
contain efflux pump inhibitors other than the active flavonoids investigated  
 
herein, as inferred from the fact that their activity cannot be explained by the  
 
presence of known active flavonoids.  Future studies to identify these compounds  
 
would be worthwhile.  Finally, more in-depth studies to explore the role of efflux  
 
pump inhibitors in plant defense would be extremely interesting. 
 
 
Table 3.1. Comparison of the Efflux Pump Inhibitory Activity, 
Antimicrobial Activity, and Flavonoid Concentration of Botanical 
Extracts Spanning the Land Plant Lineage. 
Species and family a 
(mode of acquisition, 
herbarium number) 
IC50 b MICc Active Flavonoids Present 
at Quantifiable 
Concentrationsd 
(w/w percent of extract; 
Reaction concentration at 
the IC50, in µg/mL) 
 
Marchantia spp. 
(Marchantiaceae) 
(purchasedg, NCU633652) 
150  
µg/mL 
150 
µg/mL 
Apigenin  
(3.1x10-3 %, 4.7x10-3µg/mL)         
Luteolin  
(6.5x10-3 %, 9.7x10-3µg/mL) 
Sphagnum spp. (Sphagnaceae) 
(purchasedh, NCU633524) 
150  
µg/mL 
>150 
µg/mL 
Myricetin  
(2.5x10-2 %, 3.8x10-2µg/mL) 
Diphasiastrum digitatum (Dill.) 
Holub (Lycopodiaceae) 
(collectede, NCU602026) 
150  
µg/mL 
>150  
µg/mL 
Myricetin  
(2.7x10-2 %, 4.0x10-2µg/mL) 
Osmunda claytonianaL. 
(Osmundaceae) 
(collectede, NCU602025) 
19  
µg/mL 
>150 
µg/mL 
Myricetin  
(2.4x10-2 %, 4.5x10-3µg/mL) 
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Nephrolepis exaltata (L.) Schott 
(Nephrolepidaceae) 
(Cultivatedi, NCU633530) 
>300  
µg/mL 
>150 
µg/mL 
Myricetin  
(3.1x10-2 %, 9.5x10-2µg/mL) 
Equisetum hyemale L. 
(Equisetaceae) 
(collectedf, NCU633528) 
75  
µg/mL 
>150 
µg/mL 
Myricetin  
(3.9x10-2 %, 2.9x10-2µg/mL) 
Psilotum nudum (L.) P. Beauv. 
(Psilotaceae) 
(cultivatedi, NCU633529) 
75 
µg/mL 
>150 
µg/mL 
Apigenin  
(8.9× 10-3 %, 6.7× 10-3µg/mL)        
Luteolin  
(3.0× 10-4 %, 2.3× 10-
4µg/mL)     
Rhamnetin  
(3.9× 10-3 %, 3.0× 10-
3µg/mL) 
Pinus strobus L. (Pinaceae) 
(collectede, NCU602028) 
19  
µg/mL 
>150 
µg/mL 
Apigenin  
(1.1× 10-3 %, 2.2× 10-4µg/mL)  
Kaempferol  
(1.2× 10-3 %, 2.2× 10-4µg/mL) 
Myricetin  
(2.3× 10-2 %, 4.4× 10-3µg/mL)  
Rhamnetin  
(2.8× 10-3 %, 5.4× 10-4µg/mL) 
Ginkgo biloba L. (Ginkgoaceae) 
(cultivatedi, NCU633527) 
>300  
µg/mL 
>150 
µg/mL 
Apigenin  
(1.8× 10-3 %, 5.6× 10-3µg/mL)  
Kaempferol  
(5.8× 10-4 %, 1.7× 10-3µg/mL)   
Luteolin  
(7.2× 10-4 %, 2.2× 10-3µg/mL)      
Myricetin  
(1.5× 10-2 %, 4.4× 10-2µg/mL)    
Quercetin  
(7.5× 10-3 %, 2.2× 10-2µg/mL)  
Rhamnetin  
(3.6× 10-3 %, 1.1× 10-2µg/mL) 
Cycascir cinalis L. (Cycadaceae) 
(cultivatedi, NCU633526 and 
NCU633525) 
>300  
µg/mL 
>150 
µg/mL 
Apigenin  
(4.7× 10-3 %, 1.4× 10-2µg/mL)        
Luteolin  
(4.9× 10-4 %, 1.5× 10-3µg/mL)      
Myricetin  
(3.2× 10-2 %, 9.5× 10-2µg/mL)  
Rhamnetin  
(3.3× 10-3 %, 9.9× 10-3µg/mL) 
Glaucidium palmatum 
Siebold&Zucc. (Ranunculaceae) 
(cultivatedj, NCU602023) 
>300  
µg/mL 
>150 
µg/mL 
None 
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Coptis chinensis Franch. 
(Ranunculaceae) 
(cultivatedl, NCU602015) 
75  
µg/mL 
>150 
µg/mL 
Myricetin  
(3.5× 10-2 %, 2.6× 10-2µg/mL) 
Podophyllum peltatum L. 
(Berberidaceae) 
(collectede, NCU602021) 
75  
µg/mL 
>150 
µg/mL 
Apigenin  
(4.2× 10-3 %, 3.2× 10-3µg/mL)  
Kaempferol  
(3.2× 10-1 %, 2.4× 10-1µg/mL)   
Luteolin  
(1.5× 10-4 %, 1.1× 10-4µg/mL)      
Myricetin   
(5.1× 10-2 %, 3.8× 10-2µg/mL)    
Quercetin  
(4.7× 10-2 %, 3.5× 10-2µg/mL)  
Rhamnetin  
(4.5× 10-2 %, 3.4× 10-2µg/mL) 
Zea mays L. (Poaceae) 
(purchasedk, NCU633531 and 
NCU633532) 
38  
µg/mL 
>150 
µg/mL 
Apigenin  
(1.5× 10-3 %, 5.9× 10-4µg/mL)  
Kaempferol  
(2.2× 10-3 %, 1.1× 10-3µg/mL)    
Luteolin 
(1.5× 10-4 %, 5.5× 10-5µg/mL)      
Myricetin  
(5.7× 10-2 %, 2.2× 10-2µg/mL) 
 
a.  Authorities and  validity of botanical names were verified using The Plant List 
(http://www.theplantlist.org/).   
b.  Efflux pump inhibition was measured via analysis of ethidium bromide in spent, 
filtered bacterial supernatant after a 30 min incubation, as measured by mass 
spectrometry. 
c.  Growth inhibition was measured by optical density at 600nm after an 18 hr incubation. 
d.  Flavonoid concentration was estimated based upon a calibration series of pure 
compounds, shown in Table 3.2.  Flavonoid IC50 values from previous work (Brown et 
al. 2015) are as follows: kaempherol and rhamnetin—19 µg/mL; apigenin—38 µg/mL; 
quercetin, luteolin and myricetin—75 µg/ml.  Analytical parameters are shown in 
supplemental Table 3.2. 
e. Collection location:  Near Drake Road, Dushore, Pennsylvania, United States of 
America. 
f. Collection location:  The campus of the University of North Carolina Greensboro, 
Greensboro, North Carolina, United States of America.  Near  36.44.331  latitude,  -
79.48.506 longitude.  
g. Purchased as a living specimen from Wards Natural Science, 5100 West Henrietta 
Road, PO Box 92912, Rochester, NY 14692-9012 
h. Purchased.  Original supplier: Mosser Lee Company, Millston, Wisconsin 54643, 
United States of America.  Purchased retail in Greensboro, North Carolina, United States 
of America 
48 
 
i. Cultivated (original source unknown) at the University of North Carolina at 
Greensboro, North Carolina, United States of America.  Near  36.44.331  latitude,  -
79.48.506 longitude.  The sample of Ginkgo biloba was obtained from a campus planting 
at the University of North Carolina, Greensboro.  The sample of Cycas circinalis was 
obtained from the Department of Biology plant collection, Univertsity of North Carolina, 
Greensboro. 
J. Garden origin, plants supplied by Senica Hill Perennials Fall, 2011, stored in a 
refrigerator until spring, 2012 and grown out in original pot to produce the specimen. 
k. Purchased at a farmers market, Hwy 24, Biscoe, North Carolina, United States of 
Amertica. 
l. Origin was Horizon Herbs, LLC, Post Office Box 69, Williams, Oregon 97544, United 
States of America.  
 
 
Table 3.2. Data from the Calibration Curves Used for Flavonoid 
Quantifications Presented in Table 3.1. Calibration curves were plotted as 
log-area of the relevant selected ion trace versus log-concentration. All samples 
were tested in combination at seven concentrations prepared via serial dilution 
from a starting concentration of 10 µg/mL. 
Compound Slope 
(± standard 
deviation) 
Intercept 
(± standard 
deviation) 
Standard 
Deviation 
for logY 
Concentration 
Range 
(µg/mL)a 
R2 
value 
Apigenin 8.81× 10-1 
(± 7.75× 10-2) 
8.47 
(± 1.06× 10-1) 
1.73× 10-1 5× 10-3—5 0.985 
Kaempfero
l 
1.05 
(± 6.84× 10-2) 
8.25 
(± 9.41× 10-2) 
1.53× 10-1 5× 10-3—5 0.992 
Rhamnetin 1.50 
(± 1.48× 10-1) 
7.97 
(± 1.29× 10-1) 
2.10× 10-1 5× 10-3—5 0.990 
Quercetin 1.55 
(± 1.45× 10-1) 
7.89 
(± 1.26× 10-1) 
2.05× 10-1 5× 10-2—5 0.991 
Luteolin 9.09× 10-1 
(± 5.16× 10-2) 
8.16 
(± 9.92× 10-2) 
1.63× 10-1 5× 10-4—5 0.990 
Myricetin 3.15 
(± 6.64× 10-1) 
5.72 
(± 4.82× 10-1) 
6.40× 10-1 5× 10-1—10 0.957 
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IDENTIFICATION OF FLAVONOIDS IN COMPLEX MIXTURES 
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Abstract 
 The previous two chapters have established that flavonoids act as efflux 
pump inhibitors, and that they are common in land plants.  In light of these 
observations, it stands to reason that improved methods for the study and 
identification of flavonoids would be a benefit to the field.  The present chapter 
compares two methods described in the literature for the identification of 
flavonoids in extracts.  The first of these is the analysis of fragmentation data 
generated via mass spectrometry.  The second is the usage of mass defect 
filtering data to process high resolution mass spectrometry data into a “short list” 
of potential flavonoids.  A series of studies involving pure flavonoids and fractions 
generated from an extract of goldenseal (Hydrastis canadensis) were used to 
demonstrate the potential usefulness of mass defect filtered data as a 
complement to fragmentation data. 
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Introduction 
 As has been discussed previously (Chapter I), the most common class of 
natural products that has been shown to act as efflux pump inhibitors is the 
flavonoids (Table 1.1).  Flavonoids also have a diversity of bioactivities in 
eukaryotic cells, as well as antibacterial and antiviral activity (Buer et al. 2010, 
Cushnie and Lamb 2005).  Therefore, a method for the identification of these 
compounds in crude mixtures would be very useful.  While there is a large body 
of literature pertaining to identifying and quantifying specific flavonoids, a general 
method for the identification of compounds belonging to the flavonoid chemical 
family has not yet been developed.  Zhou et al. (2007) published a paper 
identifying polymethoxylated flavones from a plant extract using tandem mass 
spectroscopy.  However, their method was primarily based on observing losses 
related to the fragmentation of the O-methyl groups.  Many compounds can 
possess these substitutions; thus, their fragmentation is not sufficient evidence to 
identify a compound as a flavonoid.   
A second approach attempting general flavonoid analysis relies most 
heavily on the usage of specialized HPLC columns, which interact well with 
flavonoids.  As a second stage of confirmation, the method identifies flavonoids 
as compounds with a peak UV absorbance of 254 nm (Huck et al. 2002).  This 
method is limited by the fact that UV detectors produce less data than mass 
spectroscopy.  While the Huck et al. (2002) report did use mass spectrometry for 
quantitation, the spectra and fragmentation patterns were not fully interpreted.   
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There are a plethora of articles that publish methods for identification of a 
specific set of flavonoids through comparison to standards, as well as articles 
describing the structural analysis of flavonoids (Abad-García et al. 2009, 
Cuyckens and Claeys 2004,Justesen 2001, March et al. 2004a, 2004b, March 
and Brodbelt 2008, Xu et al. 2012, Zhang and Brodbelt 2003), but these fall short 
of comprehensive flavonoid identification methods for complex mixtures.  To 
address this lack, we propose to evaluate two mass spectrometry approaches for 
the identification of flavonoids in complex mixtures without the a priori selection 
and usage of external standards, specifically fragmentation analysis and mass 
defect filtering. 
 The evaluation of flavonoid fragmentation and its utility performed in this 
study was based on three published cleavage patterns for flavonoids that have 
the potential to produce a manageable set of diagnostic fragments (March et al. 
2004a, 2004b).  Our studies were designed to identify key diagnostic fragments 
in a MS2 spectrum using flavonoid standards, which would allow the classification 
of unknown chemical species in a complex mixture as “probable flavonoids.”  
These three hypothesized fragmentation patterns and their likely fragments, 
supported by the literature (March et al. 2004a, 2004b), are depicted in Tables 
4.1, 4.2 and 4.3.  In the 1,3 and 1,4 fragmentation patterns (the flavonoid 
numbering is shown in Figure 4.1)  depicted in Tables 4.1 and 4.2, the C ring is 
opened.  In the 1,3 cleavage pattern, there is a subsequent rearrangement which 
preserves the A ring.  The 1,4 cleavage pattern does not produce this 
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rearrangement.  The cleavage pattern shown in Table 4.3 follows the loss of 
C2H2O from the C ring, which is followed by linkage of the B and C rings.  What 
these patterns all have in common is the fact that the A ring is relatively 
unaffected (Justesen 2001,March et al. 2004a, 2004b, March and Brodbelt 
2008), and because of this, these were selected as the most promising sources 
of diagnostic fragments.  The complete tables (Table 4.1-4.3) were composed 
using the preceding observations in the literature in combination with commonly 
observed methylations—which most often occur at carbon 6 and carbon 8.  
Additionally, secondary methylation can occur on any hydroxyl group present 
(Dewick2008).  These patterns were selected as the most likely to be diagnostic 
of the flavonoid structure because the effect the A/C fused ring system directly 
and this is more likely to be distinctive than fragments effecting the B ring only. 
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Figure 4.1. Numbering of the Flavonoid Ring System 
The flavonoid numbering and lettering system is documented in the following sources: 
(Dewick 2008, Justesen 2001, March and Brodbelt 2008) 
 
 
Since flavonoids are derived from polyketide synthesis (Dewick 2008), a 
limited number of flavonoid substitution patterns with predictable masses are 
likely to occur.   Flavonoids are commonly methylated, which most often occur at 
carbon 6 and carbon 8.  Additionally, secondary methylation can occur on any 
hydroxy group present (Dewick 2008).  In accordance with these patterns, Tables 
4.1-3 also include the masses of all potential methylated fragments (from one to 
seven methyl groups, as appropriate).   
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Table 4.1. Probable Fragments Formed Following 2,3 Cleavage of the 
Flavonoid C Ring and Subsequent Rearrangement 
a 
 
Potential 
fragment 
structureb 
   
Mass of 
fragmentc 
121.02841 137.02332 153.01824 
Fragment plus 
one methyld 
136.05134 152.04625 168.04117 
Fragment plus 
two methylsd 
151.07427 167.06918 183.06410 
Fragment plus 
three methylsd 
N/A N/A 198.08703 
 
a. The fragment formed following 2,3 cleavage of the C ring followed by rearrangement 
from the precursor molecule quercetin (March et al. 2004a, 2004b). 
b. Probable fragments formed from similar rearrangements of flavonoids of flavonoid 
aglycones, based on the known biosynthesys of flavonoids (Dewick 2008). 
c. Monoisotopic masses of the above flavonoid fragments. 
d. Monoisotopic masses of methylated flavonoid fragments, based on probable 
methylation patterns (Dewick 2008). 
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Table 4.2. Probable Fragments Formed Following 2,4 Cleavage of the 
Flavonoid C Ring 
a 
 
Potential 
fragment 
structureb 
   
Mass of 
fragmentc 
95.04914 111.04406 127.03897 
Fragment plus 
one methyld 
110.07207 126.06699 142.06190 
Fragment plus 
two methylsd 
125.09500 141.08992 157.08483 
Fragment plus 
three methylsd 
N/A 156.11285 172.10776 
Fragment plus 
four methylsd 
N/A N/A 187.13069 
 
a. The fragment formed following 2,4 cleavage of the C ring followed by rearrangement. 
from the precursor molecule quercetin (March et al. 2004a, 2004b). 
b. Probable fragments formed from similar rearrangements of flavonoids of flavonoid 
aglycones, based on the known biosynthesys of flavonoids (Dewick 2008). 
c. Monoisotopic masses of the above flavonoid fragments. 
d. Monoisotopic masses of methylated flavonoid fragments based on probable 
methylation patterns (Dewick2008). 
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Table 4.3. Probable Flavonoid Fragments and Their Masses, Following Loss of 
C2H2O and Ring Rearrangement 
a. 
 
Potential 
fragment 
structureb 
   
Mass of 
fragmentc 
197.05971 213.05462 229.04953 
Fragment plus 
one methyld 
212.08264 228.07755 244.07246 
Fragment plus 
two methylsd 
227.10557 243.10048 259.09539 
Fragment plus 
three methylsd 
N/A 258.12341 274.11832 
Fragment plus 
four methylsd 
N/A N/A 289.14125 
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Table 4.3 Continued. Probable Flavonoid Fragments and Their Masses, Following 
Loss of C2H2O and Ring Rearrangement 
Potential 
fragment 
structureb 
   
Mass of 
fragmentc 
245.04445 261.03936 277.03428 
Fragment plus 
one methyld 
260.06738 276.06229 292.05721 
Fragment plus 
two methylsd 
275.09031 291.08522 307.08014 
Fragment plus 
three methylsd 
290.11324 306.10815 322.10307 
Fragment plus 
four methylsd 
305.13617 321.13108 337.12600 
Fragment plus 
five methylsd 
320.15910 336.15401 352.14893 
Fragment plus 
six methylsd 
N/A 351.17694 367.17186 
Fragment plus 
seven methylsd 
N/A N/A 382.19479 
 
a. The fragment formed after the loss of C2H20 from the parent molecule quercetin and 
fusion of the B and C ring (March et al. 2004a, 2004b). 
b. Probable fragments formed from similar rearangements of flavonoids of flavonoid 
aglycones, based on the known biosynthesys of flavonoids (Dewick 2008). 
c. Monoisotopic masses of the above flavonoid fragments. 
d. Monoisotopic masses of methylated flavonoid fragments, based on probable 
methylation patterns (Dewick 2008). 
  
 
 The tool evaluated for the identification of possible flavonoids in plant 
extracts is the usage of mass defect filtering.  The mass defect of an ion is the 
difference between its nominal and accurate mass, and the usage of high-
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resolution instrumentation allows for the direct measurement of this intrinsic 
molecular property (Gu et al. 2011,Hughey et al. 2001, Sleno 2012, Wu et al. 
2004,Zhang et al. 2009).  Mass defect values for the four most important 
elements in organic compounds are as follows: 12C, 0.00000 Da; 1H, 0.00783 Da; 
16O, -0.00509 Da; and 14N, 0.00309 Da (Gu et al. 2011,Sleno 2012).  As can be 
seen from this, the number of carbons has no effect on the mass defect, oxygen 
has a negative effect and hydrogen has the strongest positive effect.  Because of 
this, mass defect has been shown to be a useful tool for distinguishing between 
molecules with different core carbon/hydrogen core structures (Gu et al. 2011, 
Hughey et al. 2001,Sleno 2012, Wu et al. 2004, Zhang et al. 2009). 
 There currently exist software tools capable of calculating mass defect 
from raw spectra and using it as a data filter parameter.  This allows compounds 
with related mass defect values but unrelated nominal masses to be grouped 
together and separated from the rest of the mass spectrum (Sleno 2012).   A 
review published by Zhang et al. (2009) evaluated mass defect filtering data 
produced to evaluate drug metabolites and found it to be an effective method for 
reducing background and identifying a large suite of metabolic byproducts in a 
wide range of matrices.  Further, they concluded that when compared to the 
more traditional MS2 procedure of neutral loss filtering, mass defect filtering was 
frequently more robust due to the often unpredictable nature of fragmentation 
analysis.  The study produced by (Gu et al. 2011) goes further and evaluates the 
feasibility of using mass defect filtering to successfully identify a variety of natural 
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products including flavonoids, coumarins and steroidal alkaloids in plant extracts.  
They were successful in identifying components of the mixtures belonging to all 
three groups of compounds, and suggest that the usage of more than one mass 
defect filter could be a useful technique for fingerprinting plant extracts (Gu et al. 
2011).  One shortcoming of the approach used is the fact that the mass defect 
windows of coumarins and flavonoid aglycones have a very wide region of 
overlap.  Another shortcoming that is readily identifiable from the flavonoid 
literature is the fact that the mass defect window does not include highly 
methylated aglycones.  Two examples of such aglycones include sideroxylin 
(monoisotopic mass 312.09977 Da) and tangeretin (monoisotopic mass 
372.12090 Da).  Both of these possess very high ratios of methyl groups relative 
to the number of oxygens in the molecule (Nelson 1934, Junio et al. 2011), and 
therefore have mass defects higher than the highest flavonoid mass defect 
mentioned in Gu et al. (2011), that ofpachypodol (mass defect  89.6 mDa).  
Nevertheless, the above was an excellent study and was used as the model for 
the present work with flavonoid mass defects, in combination with other 
techniques.  The goal of this study was to compare and contrast the ability of 
mass defect filtering and fragmentation analysis to distinguish compounds as 
“possible flavonoids” in complex mixtures.  Since this study did not involve 
isolation, definitive structural identifications have not been proposed. 
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Materials and Methods 
Mass spectrometry and fragmentation analysis 
 Flavonoid standards were dissolved in methanol and analyzed in 
combination at a concentration of 0.1 mg/mL  Separation of flavonoid mixtures 
was accomplished using an Aquity ultraperformance liquid chromatograph 
(UPLC) (Waters).  The chromatographic program  was performed at 0.3 mL/min 
(all ratios are CH3CN:H2O): 0 min, 10:90; 5 min, 50:50; 6 min, 50:50; 7 min, 
60:40; 7.5 min, 60:40; 8 min, 70:30; 8.5 min, 100:0; 9 min, 100:0; 9.5 min, 10:90; 
10 min, 10:90 (Brown et al. 2015).  Following separation, mass analysis was 
executed using a Q Exactive Plus mass spectrometer (Thermo Scientific) 
operated in the positive ion mode under the following conditions:  capillary 
temperature, 310 oC; sheath gas flow, 25 (arbitrary units); auxiliary gas, 5 
(arbitrary units); source voltage 3.7 kV; HESI probe temperature, 50 ºC; S lens, 
50 kV; scan range 250 m/z—325 m/z (Brown et al. 2015).  MS3 fragmentation 
was conducted by data-dependent CID at 35% collision energy, followed by a 
second data-dependent event using the HCD collision cell at 80% collision 
energy. 
 Extraction and fractionation of goldenseal 
 Goldenseal plant aerial portions were cultivated and provided by Mr. Bill 
Burch, and are represented by a vouchered specimen in the University of North 
Carolina Chapel Hill Herbarium (accession number NCU583414).  This species 
was selected due to existing experience and publications pertaining several of 
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the flavonoids it contains (Junio et al. 2011).  Plant material was air dried until 
crisp, then macerated in methanol for a minimum of 24 hrs, followed by filtration.  
The extract was dried via rotary evaporation, then re-dissolved in equal portions 
of methanol and hexanes.  These were shaken in a separatory funnel and 
allowed to separate.  The methanol partition was then added to water and 
chloroform at a ratio of 1:5:4 (methanol:water:chloroform) and allowed to 
separate again.  The chloroform partition was dried and carried on to normal 
phase liquid chromatography.  Liquid chromatography was accomplished using a 
Teledyne Isco (Lincoln, Nebraska) flash chromatography apparatus, and a 1200 
mL “Gold” silica gel column.  The chromatographic gradient was performed at 
200 mL/min using the following solvent ratios and times (all ratios are 
chloroform:methanol): 0 min, 100:0; 6 min, 100:0; 18 min, 97:3; 30 min, 90:10; 36 
min, 80:20; 42 min, 0:100; 54 min, 0:100.  Fractions were collected with a total 
volume of 250 mL, and all fractions were evaporated prior to experimental usage.   
Analysis of goldenseal extract by high resolution mass spectrometry 
 The fractions produced from the chromatographic separation of 
goldenseal were analyzed via high resolution mass spectrometry using a Q 
Exactive Plus mass spectrometer (Thermo Scientific) in combination with reverse 
phase liquid chromatography using an Aquity UPLC (Waters).  The 
chromatographic gradient was (all ratios are CH3CN:H2O): 0 min, 10:90; 5 min, 
50:50; 6 min, 50:50; 7 min, 60:40; 7.5 min, 60:40; 8 min, 70:30; 8.5 min, 100:0; 9 
min, 100:0; 9.5 min, 10:90; 10 min, 10:90.  The flow rate was 0.3 mL/min (Junio 
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2011).  Instrumental parameters were as follows: Sheath gas flow, 25 arbitrary 
units; capillary temperature, 300 ºC; source voltage, 3.5 kV; source current, 100 
µA; capillary voltage, 42 V; tube lens voltage, 42 V. 
 The chromatograms generated for all 44 fractions and the crude 
chloroform partition were initially processed using MetWorks (Thermo Scientific).  
The filter parameters limited output to a mass range of 250-400 Da, and the 
mass defect range to 37.6-121 mDa.  The mass defect range was based upon 
previously published range (Gu et al., 2011), but expanded to include the mass 
defect range for highly methylated flavonoids, as discussed in the introduction to 
this chapter.  Peaks were extracted from the mass defect filtered chromatograms 
using InteliXtract software (ACDlabs), with the data being reduced to include only 
those peaks identified as [M+H]+ with a peak area 107 instrument response units 
or greater.  This alone is inadequate for the identification of these compounds as 
flavonoids, so the data were further processed in two ways.   
Accurate mass data was further processed to determine probable 
molecular formulas using the MIDAS formula calculator, with the objective of  
determining whether or not its formula had the potential to be a flavonoid.  
Parameters provided for formula calculation were: 5 ppm or less mass accuracy, 
an unlimited number of carbon and hydrogen atoms, up to 5 nitrogen atoms, and 
up to 10 oxygen atoms.  A formula was considered a “potential flavonoid” if its 
calculated degree of hydrogen deficiency ranged from 9-12 and it possessed no 
nitrogen and more than two oxygens.  These parameters were selected based on 
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known patterns in the biosynthesis and diversity of flavonoids in plants (Dewick 
2008, Lwashina 2000) 
Results and Discussion 
The botanical extract Hydrastis canadensis was chosen as a test case in 
the study because it has previously been shown to contain flavonoids (Junio et 
al. 2011) that could serve as internal controls for the identification of “possible 
flavonoids”.   
Chromatographic separation of the H. canadensis extract produced a total 
of 44 fractions.  These were analyzed via high-resolution mass spectrometry 
followed by mass defect filtering along with the crude extract (all at a 
concentration of 1 mg/mL).  Initial processing of these data using the mass defect 
filter returned a total of 45 unique chemical entities in all fractions of the Hydrastis 
canadensis extract (data not shown).  A signal was considered a unique chemical 
entity if it had a unique paring of accurate mass and retention time data.  Of 
these, only 8 were also detected by the same analytical methodology in an un-
fractionated sample of the same H. canadensis extract (data not shown), which 
indicates the importance of the fractionation process for facilitating identification 
of relevant chemical signals.  These signals were further processed by 
calculating molecular formulas, yielding 12 compounds with the potential to be 
flavonoids.  The masses and retention times of these 12 signals are shown in 
Table 4.4. 
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Table 4.4. “Potential Flavonoids” in Hydrastis canadensis Fractions.  A total 
of 45 unique accurate mass/retention time entities were present in the mass 
defect filter results.  Of those, 12, represented here, produced a potential 
flavonoid molecular formula.   
Measured 
accurate 
mass (m/z) 
Retention 
time (min) 
Potential diagnostic 
fragments (m/z) 
[error, using 
masses in tables 
4.1, 4.2 and 4.3]a 
Flavonoid structures known 
to exist in Hydrastis 
canadensis with 
corresponding 
monoisotopic mass 
299.091 4.77 197.060 [1.5 ppm]d  
299.091 6.24 121.028 [3.4 ppm]b 
153.018 [1.6 ppm]b 
213.055 [1.8 ppm]d 
229.049 [2.3 ppm]d 
 
 
8-desmethyl-sideroxylin, 
monoisotopic mass 
298.08412e 
301.071 4.65 229.050 [2.1 ppm]d  
301.108 6.22 NFf  
313.107 6.64 137.023 [2.3 ppm]b  
 
Sideroxylin, monoisotopic 
mass 312.09978e 
315.086 4.20 NFf  
315.086 5.51 153.018 [1.6 ppm]b 
136.051 [2.5 ppm]b 
245.044 [1.8 ppm]d 
 
329.102 4.41 NDFg  
329.102 5.73 95.049 [1.5 ppm]c 
137.023 [2.3 ppm]b 
 
329.102 6.76 136.052 [4.8 ppm]b 
197.061 [6.5 ppm]d 
 
359.111 6.88 121.028 [3.4 ppm]b 
151.074 [1.8 ppm]b 
 
385.075 4.56 NFf  
 
a. Only masses matching to within 10 ppm mass accuracy were accepted 
b. Masses compared to a fragment in table 4.1 
c. Masses compared to a fragment in table 4.2 
d. Masses compared to a fragment in table 4.3 
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e. Compounds previously isolated from a Hydrastis canadensis extract (Junio et al. 
2011).  The tentative identifications for 8-desmethyl-sideroxylin and sideroxylin 
were tentatively determined by comparing the elution order to previous work 
using the same UPLC instrument and solvent gradient (Junio 2011). 
f. Samples labeled NF failed to produce a fragmentation spectrum with sufficient 
signal intensity to analyze 
g. Samples labeled NDF produce a spectrum with strong signal but no diagnostic 
fragments. 
 
 
Experiments pertaining to the usage of mass spectrometry MS2 fragmentation 
spectra showed that it was common to discover fragments from table 4.1, but 
that fragments from table 4.2 and 4.3 were lacking (data not shown).  Further 
exploration indicated that MS3 data, consisting of a low-energy initial 
fragmentation event (35% collision energy, CID) followed by a data-dependent 
second higher-energy  (80% collision energy, HCD) fragmentation event yielded 
fragments predicted by all three tables, data which is congruent with expectations 
set forth in the literature.  A sample fragmentation spectrum produced by this 
method is shown in figure 4.2.   The sample spectrum 4.2B shows masses from 
tables 4.1 and 4.2, as well as masses with the correct nominal mass but incorrect 
accurate mass, which leads to the conclusion that accurate mass measurements 
of fragments is critical for the correct interpretation of these data. 
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Figure 4.2. Sample MS2 Data (4.2A) and MS3 Data (4.2B) Derived from the 
Precursor Ion m/z 359.11.   
a. The first low-energy fragmentation (35% collision energy, CID) event resulted in 
the base peak being m/z 343.9, representing the loss of one methyl group.  This 
is a low resolution spectrum produced in the ion trap mass analyzer in the LCQ-
Orbitrap. 
b. High energy collision-induced dissociation (HCD) of the precursor mass 343.9 
revealed two masses considered to be potentially diagnostic of a flavonoid 
structure (error less than 10 ppm, values listed in Table 4.4). 
c. The indicated masses are of the correct nominal mass to be indicative of a 
flavonoid core structure, but the error is too great to have confidence in such an 
assignment (151.03850, 15 ppm mass error; 227.07025, 240 ppm mass error) 
when compared to the masses in Tables 4.1 and 4.3. 
 
 
 The MS3 fragmentation spectra for each of the 12 masses which returned 
a potential flavonoid formula were further examined and of these 8 presented 
diagnostic fragments (Table 4.4).  Additionally, 4 compounds failed to produce a 
fragmentation spectrum which could be analyzed, and only one compound 
produced a quality spectrum that lacked any diagnostic fragments (Table 4.4).  
67 
 
The masses for these compounds were compared the masses for three 
flavonoids previously isolated from goldenseal leaf material extracted by the 
same methods used here (Junio et al. 2011, Junio 2011) include sideroxylin 
(monoisotopic mass 312.09977 Da), 6-desmethyl-sideroxylin, and 8- desmethyl-
sideroxylin (isomers, monoisotopic mass 298.08412 Da).  Two of these were 
tentatively identified in the present data (Table 4.4) and thus providing an internal 
control suggesting the usefulness of these methods. 
 These data build upon, and are highly congruent with, the findings of Gu et 
al. (2011).  Both the published study and the data presented here demonstrate 
that mass defect filtering has a high potential for utility for the tentative 
identification of natural products in complex mixtures; particularly in cases where 
analytical standards are not available.  Both studies also show that mass defect 
filtering alone is inadequate for the identification of flavonoids, since other 
compounds have similar mass defect windows.  Further, these data indicate that 
the use of formula calculation is a viable method for the secondary processing of 
mass defect filtered raw data, and greatly refines the determinations made.   
Finally, it is important to remember when interpreting these data that all 
results are to be treated as tentative potential identifications, and cannot be 
treated as firm identifications in the absence of further study involving 
comparison to standards and/or isolation and structure elucidation.  These data 
also underscore the importance of utilizing high resolution mass spectrometry in 
any such study.  These results are suggestive that the flavonoid chemical 
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diversity in H. canadensis exceeds that indicated by the literature.  However, 
since the data presented here only allows the identification of a chemical signal 
as a “potential flavonoids” and cannot fully distinguish false positive results, 
further research involving the isolation and structure elucidation of these 
compounds is indicated. 
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CHAPTER V 
 
CONCLUDING REMARKS 
       
 
 The work presented in this dissertation began with a purpose of exploring 
the distribution of efflux pump inhibitors in land plants; exploring the commonality 
of efflux pump inhibitory activity within the flavonoid chemical family; and lastly 
evaluating techniques for the detection and examination of flavonoids in complex 
mixtures.  A body of preliminary experimentation rapidly indicated that new 
methods were necessary to produce the type of quantitative data needed for true 
comparisons between the level of activity present in plant extracts, as well as in 
many pure compounds.  The method that was developed made use of tandem 
mass spectrometry to observe changes in the level of ethidium bromide residual 
in filtered extracellular matrix following a 30 min exposure of bacterial cells to the 
ethidium and test compound or plant extract.  This proved useful in determining 
relative efflux pump activity, because ethidium is an efflux pump substrate that 
accumulates in cells, and is readily detectable via mass spectrometry.  The use 
of mass spectrometry allowed the ethidium signal to be readily separated from 
the complex matrix formed when bacterial growth medium and plant extracts are 
combined.  This is something not possible with the conventional optical 
instruments used in the previous literature pertaining to bacterial efflux pump 
inhibition. 
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 Once developed, this assay was successfully employed to determine the 
relative levels of efflux pump inhibitory activity present in extracts prepared from 
15 plants representing all of the main extant branches of the land plant lineage.  
All tests were carried out using the bacterium Staphylococcus aureus.  The data 
for one of these plants was presented in Chapter II, the remainder was presented 
in Chapter III of this dissertation.  In summary, all extracts except four showed 
activity against ethidium efflux in S. aureus, and there was no taxonomic pattern 
to the distribution of the plants whose extracts failed to show activity in this assay.  
This led to the conclusion that the production of bacterial efflux pump inhibition is 
widespread (though not ubiquitous) in land plants.  Further, activity against 
bacterial efflux pumps was observed in the most ancient plants examined (the 
bryophytes).  Since it is more parsimonious to assume one evolutionary origin of 
efflux pump inhibitor production than multiple origins over evolutionary time, it 
was also concluded that the production of efflux pump inhibitors is likely to have 
occurred early in the history of land plants.  This conclusion is further 
strengthened by the results indicating that flavonoids commonly possess the 
ability to inhibit ethidium efflux; because their ubiquity and ancient origin in land 
plants is well established in the literature.   
The above conclusion was then complicated by measuring the 
concentration of known active flavonoids in the active plant extracts.  These 
measurements indicated that while present, the flavonoids examined were not 
sufficiently abundant to fully explain the activity levels present in the plant 
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extracts.  This finding lead to a further conclusion that there must be additional, 
unknown chemical diversity in these extracts to explain their activity, and that 
additional experimentation is needed to fully elucidate these unknown details. 
 In light of the apparent chemical complexity underlying the ability of plant 
extracts to inhibit bacterial efflux pumps, improved methods are needed to aid in 
preliminary description of these mixtures.  In order to accomplish this goal, a 
series of techniques present in the literature were combined into a set of 
sequential steps designed to accomplish preliminary identification of a population 
of chemically related signals.  Flavonoids and an extract prepared from the plant 
Hydrastis canadensis were used as sample cases.  The crude H. canadensis 
extract was separated into 44 fractions via normal phase chromatography.  This 
proved necessary in order to concentrate uncommon chemical entities and lift 
them above the detection threshold set for the method.  Each fraction was 
subjected to UPLC-MS3 analysis using a high-resolution mass spectrometer.  
The first exclusion criteria applied was mass defect filtering, which narrowed the 
list of “possible flavonoids” down to 45 chemical entities with distinct accurate 
mass and retention times.  Formula calculation was then applied to this list, 
narrowing it down to 12 entities which yielded at least one “possible flavonoid” 
formula.  The MS3 fragmentation spectra of these 12 entities were then examined 
to determine if they contained fragments which could have been produced by 
published fragmentation patterns indicative of the flavonoid core A/C ring 
structure.  This was deemed the set of fragments most likely to be diagnostic of 
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the flavonoid chemical family in general.  This series of exclusion criteria 
produced a list of 8 “possible flavonoids”.  Of these, three can be attributed to 
compounds previously published as flavonoids produced by H. canadensis.  
There are two conclusions pertaining to this last body of research.  Firstly, the 
usage of sequential exclusion criteria beginning with intrinsic molecular 
properties does hold promise for making preliminary determinations about 
components of complex chemical mixtures.  Secondly, these data suggest that 
the flavonoid complexity of H. canadensis is richer than what the present 
literature indicates and that there is a need for additional research describing this 
richness. 
 In the final analysis, the most important component of this body of 
research may well prove to be the development of the mass spectrometry based 
assay for bacterial efflux pump inhibition.  This is because it opens doors for the 
exploration of this phenomenon that are closed without it.  While there are many 
potential uses for this method, three are specifically suggested as a continuation 
of the research presented herein.  The first of these is the exploration of efflux 
pump inhibitors outside the flavonoid chemical family, as has been discussed 
previously in this conclusion.  The second is the evaluation of efflux pump 
inhibitors in plant extracts active against plant pathogens.  The data collected 
here suggests that efflux pump inhibition may have played a role in the evolution 
of land plant disease ecology.  However, testing more bacteria in the mass 
spectrometry based efflux pump inhibition assay would provide stronger 
73 
 
evidence supporting or refuting this possibility.  Lastly, the presence of this assay 
and the quantitative phenotypic comparisons it is capable of producing are 
expected to be an asset in drug discovery research efforts aimed at curing 
antimicrobial resistant infections. 
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